Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-05-16 @ 5:55 PM
Study NCT ID:
NCT01060904
Status:
COMPLETED
Last Update Posted:
2014-12-18
First Post:
2010-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
Sponsor:
Organization: